What is Organon's SG&A?

Organon (OGN) reported SG&A of $424M in Q1 2026.

How has Organon's SG&A changed year-over-year?

Organon's SG&A increased by 1.0% year-over-year, from $420M to $424M.

What is the long-term trend for Organon's SG&A?

Over 4 years (2021 to 2025), Organon's SG&A has grown at a 0.8% compound annual growth rate (CAGR), from $1.67B to $1.72B.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Organon OGN SG&A

SG&A at other companies

PfizerPFE

$2.96B-2.3%

AmgenAMGN

$1.6B-5.0%

The Cooper Companies, Inc.COO

$676.2M+69.5%

BiogenBIIB

$607.3M+6.1%

AbbVieABBV

$3.58B+8.7%

Amneal Pharmaceuticals, Inc.AMRX

$138.86M+17.4%

Other financials

Income statement

See full

Revenue$1.5B-3.5%

Gross profit$783.0M-6.9%

Net income$146.0M+67.8%

EPS (diluted)$0.55+66.7%

Balance sheet

See full

Cash & equivalents$1.1B+104%

Total debt$8.6B-4.3%

Total equity$903.0M+66.6%

Total assets$13.0B-1.2%

Cash flow

See full

Operating cash flow$225.0M+200%

CapEx$37.0M+15.6%

Free cash flow$188.0M+337%

Valuation

See full

Market cap$3.53B-59.4%

Profitability

See full

Gross margin52.8%-4.4pp

Net margin8%-12.3pp

FCF margin11.1%-1.3pp

Returns & leverage

See full

Return on equity71.6%—

Debt / equity9.5×-7.0×

Current ratio2×+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Organon's SG&A?: Organon (OGN) reported SG&A of $424M in Q1 2026.
How has Organon's SG&A changed year-over-year?: Organon's SG&A increased by 1.0% year-over-year, from $420M to $424M.
What is the long-term trend for Organon's SG&A?: Over 4 years (2021 to 2025), Organon's SG&A has grown at a 0.8% compound annual growth rate (CAGR), from $1.67B to $1.72B.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.